Case fatality risk of diarrhoeal pathogens: a systematic review and meta-analysis.
Case fatality ratio
death
diarrhoea
heterogeneity
mortality
Journal
International journal of epidemiology
ISSN: 1464-3685
Titre abrégé: Int J Epidemiol
Pays: England
ID NLM: 7802871
Informations de publication
Date de publication:
13 10 2022
13 10 2022
Historique:
received:
06
10
2021
accepted:
06
05
2022
pubmed:
18
5
2022
medline:
15
10
2022
entrez:
17
5
2022
Statut:
ppublish
Résumé
Estimates of the relative contribution of different pathogens to all-cause diarrhoea mortality are needed to inform global diarrhoea burden models and prioritize interventions. We aimed to investigate and estimate heterogeneity in the case fatality risk (CFR) of different diarrhoeal pathogens. We conducted a systematic review and meta-analysis of studies that reported cases and deaths for 15 enteric pathogens published between 1990 and 2019. The primary outcome was the pathogen-specific CFR stratified by age group, country-specific under-5 mortality rate, setting, study year and rotavirus vaccine introduction status. We developed fixed-effects and multilevel mixed-effects logistic regression models to estimate the pooled CFR overall and for each pathogen, controlling for potential predictors of heterogeneity. A total of 416 studies met review criteria and were included in the analysis. The overall crude CFR for all pathogens was 0.65%, but there was considerable heterogeneity between and within studies. The overall CFR estimated from a random-effects model was 0.04% (95% CI: 0.026%-0.062%), whereas the pathogen-specific CFR estimates ranged from 0% to 2.7%. When pathogens were included as predictors of the CFR in the overall model, the highest and lowest odds ratios were found for enteropathogenic Escherichia coli (EPEC) [odds ratio (OR) = 3.0, 95% CI: 1.28-7.07] and rotavirus (OR = 0.23, 95% CI: 0.13-0.39), respectively. We provide comprehensive estimates of the CFR across different diarrhoeal pathogens and highlight pathogens for which more studies are needed. The results motivate the need for diarrhoeal interventions and could help prioritize pathogens for vaccine development.
Sections du résumé
BACKGROUND
Estimates of the relative contribution of different pathogens to all-cause diarrhoea mortality are needed to inform global diarrhoea burden models and prioritize interventions. We aimed to investigate and estimate heterogeneity in the case fatality risk (CFR) of different diarrhoeal pathogens.
METHODS
We conducted a systematic review and meta-analysis of studies that reported cases and deaths for 15 enteric pathogens published between 1990 and 2019. The primary outcome was the pathogen-specific CFR stratified by age group, country-specific under-5 mortality rate, setting, study year and rotavirus vaccine introduction status. We developed fixed-effects and multilevel mixed-effects logistic regression models to estimate the pooled CFR overall and for each pathogen, controlling for potential predictors of heterogeneity.
RESULTS
A total of 416 studies met review criteria and were included in the analysis. The overall crude CFR for all pathogens was 0.65%, but there was considerable heterogeneity between and within studies. The overall CFR estimated from a random-effects model was 0.04% (95% CI: 0.026%-0.062%), whereas the pathogen-specific CFR estimates ranged from 0% to 2.7%. When pathogens were included as predictors of the CFR in the overall model, the highest and lowest odds ratios were found for enteropathogenic Escherichia coli (EPEC) [odds ratio (OR) = 3.0, 95% CI: 1.28-7.07] and rotavirus (OR = 0.23, 95% CI: 0.13-0.39), respectively.
CONCLUSION
We provide comprehensive estimates of the CFR across different diarrhoeal pathogens and highlight pathogens for which more studies are needed. The results motivate the need for diarrhoeal interventions and could help prioritize pathogens for vaccine development.
Identifiants
pubmed: 35578827
pii: 6586602
doi: 10.1093/ije/dyac098
pmc: PMC9557849
doi:
Substances chimiques
Rotavirus Vaccines
0
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1469-1480Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Organisme : NIAID NIH HHS
ID : R01 AI112970
Pays : United States
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of the International Epidemiological Association.
Références
J Trop Pediatr. 2019 Dec 1;65(6):583-591
pubmed: 31330028
N Engl J Med. 2010 Jan 28;362(4):299-305
pubmed: 20107215
PLoS Med. 2021 Sep 30;18(9):e1003814
pubmed: 34591862
East Mediterr Health J. 2005 Jan-Mar;11(1-2):6-13
pubmed: 16532666
Trop Med Health. 2019 May 02;47:29
pubmed: 31073272
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
PLoS One. 2012;7(1):e29151
pubmed: 22235266
Bull World Health Organ. 2000;78(10):1246-55
pubmed: 11100619
Lancet. 2016 Oct 8;388(10053):1459-1544
pubmed: 27733281
Bull World Health Organ. 2008 Sep;86(9):710-7
pubmed: 18797647
Nutr Rev. 2000 Mar;58(3 Pt 1):80-7
pubmed: 10812923
PLoS One. 2013 Sep 04;8(9):e72788
pubmed: 24023773
Lancet Infect Dis. 2018 Nov;18(11):1211-1228
pubmed: 30243583
J Glob Health. 2019 Dec;9(2):020801
pubmed: 31673345
Bull World Health Organ. 2000;78(10):1207-21
pubmed: 11100616
Pediatr Infect Dis J. 2016 Jun;35(6):e180-90
pubmed: 26991061
Vaccine. 2020 Jun 26;38(31):4792-4800
pubmed: 32253097
Epidemiol Infect. 2010 Sep;138(9):1215-26
pubmed: 20307341
JAMA. 1991 Jun 26;265(24):3280-4
pubmed: 2046110
J Glob Health. 2019 Jun;9(1):0010503
pubmed: 31131105
Lancet Glob Health. 2018 Sep;6(9):e1036-e1044
pubmed: 30103981
PLoS Med. 2012;9(7):e1001256
pubmed: 22802736
Lancet. 2013 Jul 20;382(9888):209-22
pubmed: 23680352
BMC Public Health. 2016 Aug 19;16:830
pubmed: 27538438
Glob Health Action. 2017;10(1):1329961
pubmed: 28621206
Indian Pediatr. 1995 Mar;32(3):313-21
pubmed: 8613286
J Am Coll Nutr. 1999 Aug;18(4):303-8
pubmed: 12038472
Jpn J Infect Dis. 2010 May;63(3):204-7
pubmed: 20495276
BMJ Glob Health. 2018 Jun 04;3(3):e000762
pubmed: 29915670
Lancet. 2020 Jun 6;395(10239):1779-1801
pubmed: 32513411
Lancet Infect Dis. 2018 Nov;18(11):1229-1240
pubmed: 30266330
Lancet Glob Health. 2020 Feb;8(2):e204-e214
pubmed: 31864916
Am J Trop Med Hyg. 2013 Aug;89(2):223-8
pubmed: 23817334
Bull World Health Organ. 2003;81(3):197-204
pubmed: 12764516
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120